BioMarin appoints Robert Plenge to its board
BioMarin appointed Robert Plenge, EVP and Chief Research Officer at Bristol Myers Squibb, to its Board of Directors, effective Sept. 10, 2026.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.